Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-002055
Filing Date
2006-03-31
Accepted
2006-03-31 16:15:25
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b58514ipe10vk.htm 10-K 912368
2 EX-10.54 EMPLOYMENT AGREEMENT - ROBERT W. KARR b58514ipexv10w54.txt EX-10.54 43793
3 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b58514ipexv23w1.txt EX-23.1 1091
4 EX-31.1 SECTION 302 CERTIFICATION OF THE C.E.O. b58514ipexv31w1.txt EX-31.1 3544
5 EX-31.2 SECTION 302 CERTIFICATION OF THE C.F.O. b58514ipexv31w2.txt EX-31.2 3562
6 EX-32.1 SECTION 906 CERTIFICATION OF THE C.E.O. b58514ipexv32w1.txt EX-32.1 1565
7 EX-32.2 SECTION 906 CERTIFICATION OF THE C.F.O. b58514ipexv32w2.txt EX-32.2 1560
  Complete submission text file 0000950135-06-002055.txt   968975
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 06729087
SIC: 2836 Biological Products, (No Diagnostic Substances)